| Nephrotic Syndrome
Albuked 25% vs Rayos
Side-by-side clinical, coverage, and cost comparison for nephrotic syndrome.Deep comparison between: Albuked vs Rayos with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsRayos has a higher rate of injection site reactions vs Albuked based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Rayos but not Albuked, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Albuked
Rayos
At A Glance
IV infusion
Plasma volume expander
Oral
Daily
Corticosteroid
Indications
- Hypoproteinemia
- Respiratory Distress Syndrome, Adult
- Liver Failure, Acute
- Erythroblastosis, Fetal
- Peritonitis
- Pancreatitis
- Mediastinitis
- Cellulitis
- Nephrotic Syndrome
- Dermatitis, Atopic
- Allergic rhinitis (disorder)
- Serum Sickness
- Dermatitis Herpetiformis
- Contact Dermatitis
- Exfoliative dermatitis
- Mycosis Fungoides
- Pemphigus
- Erythema Multiforme
- Congenital Adrenal Hyperplasia
- Hypercalcemia
- thyroiditis; nonsuppurative
- Adrenal gland hypofunction
- Crohn Disease
- Ulcerative Colitis
- Autoimmune hemolytic anemia
- Anemia, Diamond-Blackfan
- Immune thrombocytopenic purpura
- Pure Red-Cell Aplasia
- Acute leukemia
- Lymphoma, Non-Hodgkin
- Multiple Sclerosis
- Cerebral Edema
- Ophthalmia, Sympathetic
- Uveitis
- Chronic Obstructive Airway Disease
- Aspergillosis, Allergic Bronchopulmonary
- Aspiration pneumonitis
- Asthma
- Tuberculosis
- Extrinsic allergic alveolitis
- Bronchiolitis Obliterans Organizing Pneumonia
- Idiopathic eosinophilic pneumonitis
- Idiopathic Pulmonary Fibrosis
- Pneumonia, Lipid
- Sarcoidosis
- Nephrotic Syndrome
- Primary gout
- Ankylosing spondylitis
- Dermatomyositis
- Polymyalgia Rheumatica
- Arthritis, Psoriatic
- Polychondritis, Relapsing
- Rheumatoid Arthritis
- Sjogren's Syndrome
- Lupus Erythematosus, Systemic
- Vasculitis
- Trichinellosis
- Tuberculosis, Meningeal
Dosing
Hypovolemic Shock Volume administered and speed of infusion adapted to the response of the individual patient; IV infusion.
Burns Beyond 24 hours post-injury, maintain plasma albumin ~2.5 +/- 0.5 g per 100 mL with plasma oncotic pressure of 20 mm Hg; IV infusion.
Hypoproteinemia 50-75 g daily (adults), 25 g daily (children); rate not exceeding 2 mL/min; IV infusion.
All indications Initial dose 5-60 mg once daily with food; RAYOS releases active substance approximately 4 hours after intake. Titrate to lowest effective maintenance dose; withdraw gradually after long-term or high-dose therapy.
Contraindications
- History of congestive cardiac failure, renal insufficiency, or stabilized chronic anemia (risk of circulatory overload)
- History of allergic reaction to albumin
- Known hypersensitivity to prednisone or any excipient
Adverse Reactions
Allergic urticaria, chills, fever, changes in respiration, pulse, and blood pressure
From excessive administration high plasma protein levels
Most common Fluid retention, altered glucose tolerance, elevated blood pressure, behavioral and mood changes, increased appetite and weight gain
Serious Anaphylaxis, cardiac arrest, circulatory collapse, congestive heart failure, myocardial rupture, pulmonary edema, peptic ulcer with perforation and hemorrhage, osteonecrosis, pathologic fracture, adrenocortical insufficiency, convulsions, increased intracranial pressure
Postmarketing No new safety concerns identified beyond those established for immediate-release prednisone
Pharmacology
Albumin (Human) is a plasma protein that exerts oncotic (colloid osmotic) pressure, expanding plasma volume by drawing fluid from extravascular tissues; it also functions as a transport protein capable of binding substances such as bilirubin.
Prednisone is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties that suppresses inflammatory processes (edema, capillary dilatation, leukocyte migration), modifies immune responses, and produces metabolic effects including promotion of gluconeogenesis, protein catabolism, and altered calcium and electrolyte balance.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Albuked
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
Rayos
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (1/12) · Qty limit (0/12)
UnitedHealthcare
Albuked
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Rayos
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Albuked
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Rayos
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Albuked.
No savings programs available for Rayos.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
AlbukedView full Albuked profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.